AJR Get Involved! Great Benefits! Join ARRS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daldrup, H.
Right arrow Articles by Brasch, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daldrup, H.
Right arrow Articles by Brasch, R. C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 171, 941-949, Copyright © 1998 by American Roentgen Ray Society

ARTICLES

Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media

H Daldrup, DM Shames, M Wendland, Y Okuhata, TM Link, W Rosenau, Y Lu and RC Brasch
Department of Radiology, University of California, San Francisco 94143- 0628, USA.

OBJECTIVE: The endothelial integrity of microvessels is disrupted in malignant tumors. Quantitative assays of tumor microvascular characteristics based on dynamic MR imaging were correlated with histopathologic grade in mammary soft-tissue tumors. MATERIALS AND METHODS: A spectrum of tumors, benign through highly malignant, was induced in 33 female rats by administration of N-ethyl-N-nitrosourea, a potent carcinogen. Dynamic contrast-enhanced MR imaging was performed using a small-molecular contrast medium (gadopentetate, molecular weight = 0.5 kDa) and a macromolecular contrast medium (albumin-(Gd- DTPA)30, molecular weight = 92 kDa) at an interval of 1-2 days. Permeability surface area product (PS), as estimated by the corresponding endothelial transfer coefficient (K(PS)), and fractional plasma volume (fPV) were calculated for each tumor and each contrast agent using a two-compartment bidirectional kinetic model. MR imaging microvascular characteristics were correlated with histopathologic tumor grade. RESULTS: Tumor permeability to macromolecular contrast medium, characterized by K(PS), showed a highly positive correlation with tumor grade (r2 = .76, p < 10(-10)). K(PS) values were zero for all benign and some low-grade carcinomas, greater than zero in all other carcinomas, and increased in magnitude with higher tumor grade. A considerably smaller but significantly positive correlation was found between fPV and tumor grade using macromolecular contrast medium (r2 = .25, p < .003). No correlation between K(PS) or fPV values and tumor grade was found using gadopentetate (r2 = .01, p > .95 and r2 = .03, p > .15, respectively). CONCLUSION: Quantitative tumor microvascular permeability assays generated with macromolecular MR imaging contrast medium correlate closely with histologic tumor grade. No significant correlation is found using small-molecular gadopentetate.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
M. Oostendorp, K. Douma, T. M. Hackeng, A. Dirksen, M. J. Post, M. A.M.J. van Zandvoort, and W. H. Backes
Quantitative Molecular Magnetic Resonance Imaging of Tumor Angiogenesis Using cNGR-Labeled Paramagnetic Quantum Dots
Cancer Res., September 15, 2008; 68(18): 7676 - 7683.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
H.-J. Raatschen, G. H. Simon, Y. Fu, B. Sennino, D. M. Shames, M. F. Wendland, D. M. McDonald, and R. C. Brasch
Vascular Permeability during Antiangiogenesis Treatment: MR Imaging Assay Results as Biomarker for Subsequent Tumor Growth in Rats
Radiology, May 1, 2008; 247(2): 391 - 399.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
R. Jain, S.K. Ellika, L. Scarpace, L.R. Schultz, J.P. Rock, J. Gutierrez, S.C. Patel, J. Ewing, and T. Mikkelsen
Quantitative Estimation of Permeability Surface-Area Product in Astroglial Brain Tumors Using Perfusion CT and Correlation with Histopathologic Grade
AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 694 - 700.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
L. S. Fournier, V. Novikov, V. Lucidi, Y. Fu, T. Miller, E. Floyd, D. M. Shames, and R. C. Brasch
MR Monitoring of Cyclooxygenase-2 Inhibition of Angiogenesis in a Human Breast Cancer Model in Rats
Radiology, April 1, 2007; 243(1): 105 - 111.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. I. Lin, J. Yu, T. Murata, and W. C. Sessa
Caveolin-1-Deficient Mice Have Increased Tumor Microvascular Permeability, Angiogenesis, and Growth
Cancer Res., March 15, 2007; 67(6): 2849 - 2856.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
A Khiat, D Gianfelice, M Amara, and Y Boulanger
Influence of post-treatment delay on the evaluation of the response to focused ultrasound surgery of breast cancer by dynamic contrast enhanced MRI.
Br. J. Radiol., April 1, 2006; 79(940): 308 - 314.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
A. S. Doria, M. Noseworthy, W. Oakden, R. Moineddin, T. Rayner, V. Tassos, D. Engelberts, K. Pritzker, M. Rogers, R. Jong, et al.
Dynamic contrast-enhanced MRI quantification of synovium microcirculation in experimental arthritis.
Am. J. Roentgenol., April 1, 2006; 186(4): 1165 - 1171.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
Q. G. de Lussanet, S. Langereis, R. G. H. Beets-Tan, M. H. P. van Genderen, A. W. Griffioen, J. M. A. van Engelshoven, and W. H. Backes
Dynamic Contrast-enhanced MR Imaging Kinetic Parameters and Molecular Weight of Dendritic Contrast Agents in Tumor Angiogenesis in Mice
Radiology, April 1, 2005; 235(1): 65 - 72.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
T. J. Kim, W. K. Moon, J. H. Cha, J. M. Goo, K. H. Lee, K. H. Kim, J. W. Lee, J. G. Han, H.-J. Weinmann, and K. H. Chang
VX2 Carcinoma in Rabbits after Radiofrequency Ablation: Comparison of MR Contrast Agents for Help in Differentiating Benign Periablational Enhancement from Residual Tumor
Radiology, February 1, 2005; 234(2): 423 - 430.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. F. Jordan, M. Runquist, N. Raghunand, R. J. Gillies, W. R. Tate, G. Powis, and A. F. Baker
The Thioredoxin-1 Inhibitor 1-Methylpropyl 2-Imidazolyl Disulfide (PX-12) Decreases Vascular Permeability in Tumor Xenografts Monitored by Dynamic Contrast Enhanced Magnetic Resonance Imaging
Clin. Cancer Res., January 15, 2005; 11(2): 529 - 536.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
W. Huang, P. R. Fisher, K. Dulaimy, L. A. Tudorica, B. O'Hea, and T. M. Button
Detection of Breast Malignancy: Diagnostic MR Protocol for Improved Specificity
Radiology, August 1, 2004; 232(2): 585 - 591.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
A R Padhani
MRI for assessing antivascular cancer treatments
Br. J. Radiol., December 1, 2003; 76(suppl_1): S60 - S80.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
H. E. Daldrup-Link, J. Rydland, T. H. Helbich, A. Bjornerud, K. Turetschek, K. A. Kvistad, E. Kaindl, T. M. Link, K. Staudacher, D. Shames, et al.
Quantification of Breast Tumor Microvascular Permeability with Feruglose-enhanced MR Imaging: Initial Phase II Multicenter Trial
Radiology, December 1, 2003; 229(3): 885 - 892.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. Morgan, A. L. Thomas, J. Drevs, J. Hennig, M. Buchert, A. Jivan, M. A. Horsfield, K. Mross, H. A. Ball, L. Lee, et al.
Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Biomarker for the Pharmacological Response of PTK787/ZK 222584, an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, in Patients With Advanced Colorectal Cancer and Liver Metastases: Results From Two Phase I Studies
J. Clin. Oncol., November 1, 2003; 21(21): 3955 - 3964.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
Q. G. de Lussanet, W. H. Backes, A. W. Griffioen, J. M. A. van Engelshoven, and R. G. H. Beets-Tan
Gadopentetate Dimeglumine versus Ultrasmall Superparamagnetic Iron Oxide for Dynamic Contrast-enhanced MR Imaging of Tumor Angiogenesis in Human Colon Carcinoma in Mice
Radiology, November 1, 2003; 229(2): 429 - 438.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Giavazzi, B. Sennino, D. Coltrini, A. Garofalo, R. Dossi, R. Ronca, M. P. M. Tosatti, and M. Presta
Distinct Role of Fibroblast Growth Factor-2 and Vascular Endothelial Growth Factor on Tumor Growth and Angiogenesis
Am. J. Pathol., June 1, 2003; 162(6): 1913 - 1926.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
H. C. Roberts, T. P.L. Roberts, T.-Y. Lee, and W. P. Dillon
Dynamic, Contrast-Enhanced CT of Human Brain Tumors: Quantitative Assessment of Blood Volume, Blood Flow, and Microvascular Permeability: Report of Two Cases
AJNR Am. J. Neuroradiol., May 1, 2002; 23(5): 828 - 832.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
E. Fosslien
Molecular Pathology of Cyclooxygenase-2 in Cancer-induced Angiogenesis
Ann. Clin. Lab. Sci., October 1, 2001; 31(4): 325 - 348.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
K. Turetschek, S. Huber, E. Floyd, T. Helbich, T. P. L. Roberts, D. M. Shames, K. S. Tarlo, M. F. Wendland, and R. C. Brasch
MR Imaging Characterization of Microvessels in Experimental Breast Tumors by Using a Particulate Contrast Agent with Histopathologic Correlation
Radiology, February 1, 2001; 218(2): 562 - 569.
[Abstract] [Full Text]

Home page
 Am. J. Neuroradiol.Home page
H. C. Roberts, T. P. L. Roberts, R. C. Brasch, and W. P. Dillon
Quantitative Measurement of Microvascular Permeability in Human Brain Tumors Achieved Using Dynamic Contrast-enhanced MR Imaging: Correlation with Histologic Grade
AJNR Am. J. Neuroradiol., May 1, 2000; 21(5): 891 - 899.
[Abstract] [Full Text]

Home page
 Am. J. Roentgenol.Home page
W. K. Moon, K. H. Chang, H.-J. Weinmann, Y. H. Koh, J.-G. Im, K. M. Yeon, and M. C. Han
Dynamic Contrast-Enhanced MR Imaging of Bacterial Abscess and VX2 Carcinoma in Rabbits: Comparison of Gadopentetate Dimeglumine and a Macromolecular Contrast Agent
Am. J. Roentgenol., May 1, 2000; 174(5): 1385 - 1389.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
H. Hashizume, P. Baluk, S. Morikawa, J. W. McLean, G. Thurston, S. Roberge, R. K. Jain, and D. M. McDonald
Openings between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Am. J. Pathol., April 1, 2000; 156(4): 1363 - 1380.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
A. Gossmann, Y. Okuhata, D. M. Shames, T. H. Helbich, T. P. L. Roberts, M. F. Wendland, S. Huber, and R. C. Brasch
Prostate Cancer Tumor Grade Differentiation with Dynamic Contrast-enhanced MR Imaging in the Rat: Comparison of Macromolecular and Small-Molecular Contrast Media-Preliminary Experience
Radiology, October 1, 1999; 213(1): 265 - 272.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. Ntziachristos, A. G. Yodh, M. Schnall, and B. Chance
Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement
PNAS, March 14, 2000; 97(6): 2767 - 2772.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Roentgen Ray Society.